SCOPUS 정보 검색 플랫폼

International Immunopharmacology

Volumn 6, Issue 4, 2006, Pages 550-556

The role of high-dose immune globulin intravenous in the treatment of dermatomyositis

(1) Dalakas, Marinos C a

a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STEROID; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD VESSEL DIAMETER; CAPILLARY; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DERMATOMYOSITIS; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; HISTOLOGY; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; MUSCLE BIOPSY; MUSCLE STRENGTH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RASH; REGULATOR GENE; REVIEW; STRUCTURAL GENE; T LYMPHOCYTE;

EID: 33644557720 PISSN: 15675769 EISSN: None Source Type: Journal
DOI: 10.1016/j.intimp.2005.11.016 Document Type: Article

Times cited : (41)

References (19)

1
- 0026429550
- Polymyositis, dermatomyositis, and inclusion-body myositis
- M.C. Dalakas Polymyositis, dermatomyositis, and inclusion-body myositis New Engl J Med 325 1991 1487 1498
- (1991) New Engl J Med , vol.325 , pp. 1487-1498
- Dalakas, M.C.¹

2
- 0141651951
- Polymyositis and dermatomyositis
- M.C. Dalakas, and R. Hohlfeld Polymyositis and dermatomyositis Lancet 362 2003 971 982
- (2003) Lancet , vol.362 , pp. 971-982
- Dalakas, M.C.¹ Hohlfeld, R.²

3
- 6944247647
- Molecular studies in autoimmune inflammatory muscle disorders
- M.C. Dalakas Molecular studies in autoimmune inflammatory muscle disorders Curr Opin Neurol 17 2004 561 567
- (2004) Curr Opin Neurol , vol.17 , pp. 561-567
- Dalakas, M.C.¹

4
- 0041842435
- Therapeutic approaches in patients with inflammatory myopathies
- M.C. Dalakas Therapeutic approaches in patients with inflammatory myopathies Semin Neurol 23 2003 199 206
- (2003) Semin Neurol , vol.23 , pp. 199-206
- Dalakas, M.C.¹

5
- 0041813854
- The treatment of polymyositis, dermatomyositis, and inclusion body myositis
- R.T. Johnson J.W. Griffin Mosby/Year Book St. Louis
- M.C. Dalakas The treatment of polymyositis, dermatomyositis, and inclusion body myositis R.T. Johnson J.W. Griffin Current therapy in neurology 1996 Mosby/Year Book St. Louis 407 412
- (1996) Current Therapy in Neurology , pp. 407-412
- Dalakas, M.C.¹

6
- 0024943098
- Treatment of polymyositis and dermatomyositis
- M.C. Dalakas Treatment of polymyositis and dermatomyositis Curr Opin Rheumatol 1 1989 443 449
- (1989) Curr Opin Rheumatol , vol.1 , pp. 443-449
- Dalakas, M.C.¹

7
- 0026598194
- Controlled trial of plasma exchange and leukopheresis in polymyositis and dermatomyositis
- F.W. Miller, S.F. Leitman, M.E. Cronin, J.E. Hicks, R.L. Leff, and R. Wesley Controlled trial of plasma exchange and leukopheresis in polymyositis and dermatomyositis N Engl J Med 326 1992 1380 1384
- (1992) N Engl J Med , vol.326 , pp. 1380-1384
- Miller, F.W.¹ Leitman, S.F.² Cronin, M.E.³ Hicks, J.E.⁴ Leff, R.L.⁵ Wesley, R.⁶

8
- 0026074908
- Efficacy of intravenous immunoglobulin therapy in chronic refractory polymyositis and dermatomyositis. An open study with 20 adult patients
- P. Cherin, S. Herson, B. Wechsler, J.C. Piette, O. Bletry, and A. Coutellier Efficacy of intravenous immunoglobulin therapy in chronic refractory polymyositis and dermatomyositis. An open study with 20 adult patients Am J Med 91 1991 162 168
- (1991) Am J Med , vol.91 , pp. 162-168
- Cherin, P.¹ Herson, S.² Wechsler, B.³ Piette, J.C.⁴ Bletry, O.⁵ Coutellier, A.⁶

9
- 0026055719
- Treatment of dermatomyositis with intravenous immunoglobulin
- B.A. Lang, R.M. Laxer, G. Murphy, E.D. Silverman, and C.M. Roifman Treatment of dermatomyositis with intravenous immunoglobulin Am J Med 91 1991 169 172
- (1991) Am J Med , vol.91 , pp. 169-172
- Lang, B.A.¹ Laxer, R.M.² Murphy, G.³ Silverman, E.D.⁴ Roifman, C.M.⁵

10
- 0026503279
- High-dose intravenous human immunoglobulin in polymyositis resistant to treatment
- S. Jann, S. Beretta, M. Moggio, L. Adobbati, and G. Pellegrini High-dose intravenous human immunoglobulin in polymyositis resistant to treatment J Neurol Neurosurg Psychiatry 55 1992 60 64
- (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 60-64
- Jann, S.¹ Beretta, S.² Moggio, M.³ Adobbati, L.⁴ Pellegrini, G.⁵

11
- 0027159872
- Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin
- S.A. Soueidan, and M.C. Dalakas Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin Neurology 43 1993 876 879
- (1993) Neurology , vol.43 , pp. 876-879
- Soueidan, S.A.¹ Dalakas, M.C.²

12
- 0030947027
- Treatment of inclusion body, myositis with IVIg: A double blind, placebo controlled study
- M.C. Dalakas, B. Sonies, J. Dambrosia, E. Sekul, E. Cuplerm, and K. Sivakumar Treatment of inclusion body, myositis with IVIg: a double blind, placebo controlled study Neurology 48 1997 712 716
- (1997) Neurology , vol.48 , pp. 712-716
- Dalakas, M.C.¹ Sonies, B.² Dambrosia, J.³ Sekul, E.⁴ Cuplerm, E.⁵ Sivakumar, K.⁶

13
- 0030848216
- Signal transducer and activator of transcription 1 in human muscle: Implications in inflammatory myopathies
- I. Illa, E. Gallardo, R. Gimeno, C. Serrano, I. Ferrer, and C. Juarez Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies Am J Pathol 151 1997 81 88
- (1997) Am J Pathol , vol.151 , pp. 81-88
- Illa, I.¹ Gallardo, E.² Gimeno, R.³ Serrano, C.⁴ Ferrer, I.⁵ Juarez, C.⁶

14
- 0027729939
- A controlled trial of high-dose intravenous immunoglobulin infusions as treatment for dermatomyositis
- M.C. Dalakas, I. Illa, J.M. Dambrosia, S.A. Soueidan, D.P. Stein, and C. Otero A controlled trial of high-dose intravenous immunoglobulin infusions as treatment for dermatomyositis N Engl J Med 329 1993 1993 2000
- (1993) N Engl J Med , vol.329 , pp. 1993-2000
- Dalakas, M.C.¹ Illa, I.² Dambrosia, J.M.³ Soueidan, S.A.⁴ Stein, D.P.⁵ Otero, C.⁶

15
- 0028297292
- Intravenous immune globulin for dermatomyositis
- M.C. Dalakas Intravenous immune globulin for dermatomyositis N Engl J Med 330 1994 1392 1393
- (1994) N Engl J Med , vol.330 , pp. 1392-1393
- Dalakas, M.C.¹

16
- 0033621610
- Down-regulation of TGF-β1, mRNA, and protein in the muscle of patients with inflammatory myopathy after treatment with high-dose intravenous immunoglobulin
- K. Amemiya, C. Semino-Mora, R.P. Granger, and M.C. Dalakas Down-regulation of TGF-β1, mRNA, and protein in the muscle of patients with inflammatory myopathy after treatment with high-dose intravenous immunoglobulin Clin Immunol 94 2000 99 104
- (2000) Clin Immunol , vol.94 , pp. 99-104
- Amemiya, K.¹ Semino-Mora, C.² Granger, R.P.³ Dalakas, M.C.⁴

17
- 0028113940
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
- M. Basta, and M.C. Dalakas High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments J Clin Invest 94 1994 1729 1735
- (1994) J Clin Invest , vol.94 , pp. 1729-1735
- Basta, M.¹ Dalakas, M.C.²

18
- 2442531717
- Intravenous immunoglobulin in autoimmune neuromuscular diseases
- M.C. Dalakas Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2004 2367 2375
- (2004) JAMA , vol.291 , pp. 2367-2375
- Dalakas, M.C.¹

19
- 3042856624
- The role of IVIg in the treatment of autoimmune neurological disorders: Evidence based indications and safety profile
- M.C. Dalakas The role of IVIg in the treatment of autoimmune neurological disorders: evidence based indications and safety profile Pharmacol Ther 102 2004 177 193
- (2004) Pharmacol Ther , vol.102 , pp. 177-193
- Dalakas, M.C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.